about this project
About Reviews Tesa
An independent editorial digest of the published tesamorelin research — walked node by node, cited to source.
What this site is
Reviews Tesa is an independent editorial project that publishes summaries of the peer-reviewed research literature on tesamorelin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science — the published trials, the reviews, the FDA label, and the NIH drug-safety record.
The "reviews" in our name describes exactly what we do: we review the literature. We read the tesamorelin studies, organize them as a walk-the-board timeline, and summarize what each one measured, in plain English, with every quantitative claim cited to its source.
How we work
Our method is simple and deliberately conservative. We lead with what the studies measured — the numbers, the populations, the doses, the durations — and we attribute every figure to a numbered citation you can follow to PubMed, the NCBI Bookshelf, or the FDA. We describe research findings; we do not recommend doses for any individual, and we give no human dosing instructions.
We are careful about scope. Tesamorelin is FDA-approved for one indication only — reducing excess abdominal fat in HIV-associated lipodystrophy — and we say so plainly wherever the question of approval comes up. Where the evidence is strong, we say it is strong. Where it stops — for example, the absence of large non-HIV fat-loss trials — we mark the boundary rather than paper over it.
A note on the name
Our domain carries the word "reviews." That is editorial framing — the position we occupy relative to the literature — not a claim about clinical services. We do not review patients; we review studies. We offer no consultation, no treatment, and no prescription. If you have a medical question about growth-hormone-axis therapy or HIV-associated lipodystrophy, that belongs with a qualified healthcare professional, not with an editorial digest. What we offer is a clear, cited reading of what the published research on tesamorelin actually shows.